[{"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q1_USD":6123000.0,"IncreaseDecreaseInContractWithCustomerLiability_1_Q1_USD":-474000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":30859000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_1_Q1_USD":0.0,"InvestmentIncomeInterest_1_Q1_USD":47000.0,"DefinedContributionPlanEmployerDiscretionaryContributionAmount_1_Q1_USD":0.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-6094000.0,"IncreaseDecreaseInOtherOperatingAssets_1_Q1_USD":-427000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q1_USD":7031000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":912000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q1_USD":262000.0,"NonoperatingIncomeExpense_1_Q1_USD":47000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":38000.0,"ShareBasedCompensation_1_Q1_USD":769000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":9498000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":155657000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":769000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":1185000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":507000.0,"SeveranceCosts1_1_Q1_USD":1700000.0,"RestructuringReserve_0_Q1_USD":562000.0,"RestructuringCharges_1_Q1_USD":1700000.0,"RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent_1_Q1_pure":0.6,"RestrictedCashNoncurrent_0_Q1_USD":1255000.0,"PurchaseObligation_0_Q1_USD":300000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_1_Q1_USD":35000.0,"PaymentsForRestructuring_1_Q1_USD":1138000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":4929000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":3987000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":1658000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_1_Q1_USD":-1008000.0,"ContractWithCustomerLiabilityCurrent_0_Q1_USD":841000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-7820000.0,"AssetsFairValueDisclosure_0_Q1_USD":487000.0,"PreferredStockValue_0_Q1_USD":null,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q1_USD":35000.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"PreferredStockSharesAuthorized_0_Q1_shares":10000000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":414000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":-2000000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":-2555000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":3674000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.2,"CostsAndExpenses_1_Q1_USD":13172000.0,"Liabilities_0_Q1_USD":13237000.0,"CommonStockValue_0_Q1_USD":31000.0,"CommonStockSharesIssued_0_Q1_shares":30821892.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":29604000.0,"AssetsCurrent_0_Q1_USD":31185000.0,"Assets_0_Q1_USD":38939000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":4459293.0,"AccountsPayableCurrent_0_Q1_USD":628000.0,"CommonStockSharesOutstanding_0_Q1_shares":30821892.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":38939000.0,"LiabilitiesCurrent_0_Q1_USD":9250000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":73000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.001,"OperatingIncomeLoss_1_Q1_USD":-6141000.0,"DepreciationAndAmortization_1_Q1_USD":295000.0,"CommonStockSharesAuthorized_0_Q1_shares":150000000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"CommitmentsAndContingencies_0_Q1_USD":null,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":30136749.0,"StockholdersEquity_0_Q1_USD":25702000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-129986000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":1570000.0,"ProfitLoss_1_Q1_USD":-6094000.0,"ProceedsFromIssuanceOfCommonStock_1_Q1_USD":38000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":1581000.0,"NetIncomeLoss_1_Q1_USD":-6094000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-7893000.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"TreasuryStockRetiredCostMethodAmount_1_Q1_USD":808000.0,"Ticker":"COGT","CIK":"1622229","name":"UNUM THERAPEUTICS INC.","OfficialName":"Cogent Biosciences Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"369716293.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200511"}]